Captrust Financial Advisors Albireo Pharma, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$23.94 - $33.74 $646 - $910	-27 Reduced 19.01%	115 $3,000
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $105 - $156	-5 Reduced 3.4%	142 $3,000
Q3 2021 Nov 16, 2021	BUY	$27.36 - $35.98 $164 - $215	6 Added 4.26%	147 $5,000
Q2 2021 Aug 16, 2021	SELL	$28.9 - $36.87 $173 - $221	-6 Reduced 4.08%	141 $5,000
Q1 2021 May 17, 2021	BUY	$32.03 - $42.85 $4,708 - $6,298	147 New	147 $5,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.